114 related articles for article (PubMed ID: 37130077)
21. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
22. Identification of a RNA-seq-based signature to improve prognostics for uterine sarcoma.
Zhou JG; Zhao HT; Jin SH; Tian X; Ma H
Gynecol Oncol; 2019 Dec; 155(3):499-507. PubMed ID: 31662204
[TBL] [Abstract][Full Text] [Related]
23. The development of a novel signature based on the m
Li H; Lin D; Wang X; Feng Z; Zhang J; Wang K
Front Genet; 2022; 13():894080. PubMed ID: 36313417
[No Abstract] [Full Text] [Related]
24. A signature of 24 aging‑related gene pairs predict overall survival in gastric cancer.
Zhang Y; Yan Y; Ning N; Shen Z; Ye Y
Biomed Eng Online; 2021 Apr; 20(1):35. PubMed ID: 33823856
[TBL] [Abstract][Full Text] [Related]
25. Construction and validation of an aging-related gene signature for prognosis prediction of patients with breast cancer.
Li J; Qi C; Li Q; Liu F
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1741. PubMed ID: 36323529
[TBL] [Abstract][Full Text] [Related]
26. Identification of Prognostic lncRNA Related to the Immune Microenvironment of Soft Tissue Sarcoma.
Dai WY; Wang B; Li JY; Luo ZP
Biomed Res Int; 2022; 2022():9471558. PubMed ID: 35155682
[TBL] [Abstract][Full Text] [Related]
27. A senescence-related signature for predicting the prognosis of breast cancer: A bioinformatics analysis.
Xing T; Hu Y; Wang H; Zou Q
Medicine (Baltimore); 2023 May; 102(19):e33739. PubMed ID: 37171330
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis.
Zhang C; Liu H; Xu P; Tan Y; Xu Y; Wang L; Liu B; Chen Q; Tian D
BMC Cancer; 2021 Mar; 21(1):251. PubMed ID: 33750353
[TBL] [Abstract][Full Text] [Related]
29. A Combined Risk Score Model to Assess Prognostic Value in Patients with Soft Tissue Sarcomas.
Li Z; Duan Z; Jia K; Yao Y; Liu K; Qiao Y; Gao Q; Yang Y; Li G; Shang A
Cells; 2022 Dec; 11(24):. PubMed ID: 36552841
[TBL] [Abstract][Full Text] [Related]
30. Integrative Clustering Reveals a Novel Subtype of Soft Tissue Sarcoma With Poor Prognosis.
Zhu Z; Jin Z; Zhang H; Zhang M; Sun D
Front Genet; 2020; 11():69. PubMed ID: 32127798
[TBL] [Abstract][Full Text] [Related]
31. Establishment of a prognostic signature for lung adenocarcinoma by integration of 7 pyroptosis-related genes and cross-validation between the TCGA and GEO cohorts: A comprehensive bioinformatics analysis.
Zhang W; Wan S; Qu Z; Ge J; Zhang C; Li C; Jiang Y
Medicine (Baltimore); 2022 Jul; 101(29):e29710. PubMed ID: 35866781
[TBL] [Abstract][Full Text] [Related]
32. Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer.
Xu M; Li Q; Zhang J; Xie H
Can J Gastroenterol Hepatol; 2022; 2022():5827544. PubMed ID: 35399646
[TBL] [Abstract][Full Text] [Related]
33. A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients.
Cao W; Zhou W; Li M; Zhang Z; Zhang X; Yang K; Yang S; Cao G; Chen B; Xiong M
Front Immunol; 2022; 13():951135. PubMed ID: 36483555
[TBL] [Abstract][Full Text] [Related]
34. Construction and validation of an aging-related gene signature predicting the prognosis of pancreatic cancer.
Wang D; Zhang Y; Wang X; Zhang L; Xu S
Front Genet; 2023; 14():1022265. PubMed ID: 36741321
[No Abstract] [Full Text] [Related]
35. Identification and validation of a twelve immune infiltration-related lncRNA prognostic signature for bladder cancer.
Liu CQ; Xia QD; Sun JX; Xu JZ; Lu JL; Liu Z; Hu J; Wang SG
Aging (Albany NY); 2022 Feb; 14(3):1492-1507. PubMed ID: 35165206
[TBL] [Abstract][Full Text] [Related]
36. A Complement-Related Gene Signature for Predicting Overall Survival and Immunotherapy Efficacy in Sarcoma Patients.
Zhang L; Lin W; Zhou Y; Shao F; Gao Y; He J
Front Cell Dev Biol; 2022; 10():765062. PubMed ID: 35493104
[TBL] [Abstract][Full Text] [Related]
37. Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma.
Li Z; Wang W; Wu J; Ye X
Front Med (Lausanne); 2022; 9():962972. PubMed ID: 36091687
[TBL] [Abstract][Full Text] [Related]
38. Multi-Omics Approaches Identify Necroptosis‑Related Prognostic Signature and Associated Regulatory Axis in Cervical Cancer.
Zhan J; Yang F; Ge C; Yu X
Int J Gen Med; 2022; 15():4937-4948. PubMed ID: 35592536
[TBL] [Abstract][Full Text] [Related]
39. Identification and Validation a Necroptosis‑related Prognostic Signature and Associated Regulatory Axis in Stomach Adenocarcinoma.
Wang N; Liu D
Onco Targets Ther; 2021; 14():5373-5383. PubMed ID: 34880629
[TBL] [Abstract][Full Text] [Related]
40. Identification of EMT-associated LncRNA Signature for Predicting the Prognosis of Patients with Endometrial Cancer.
Shu W; Wang Z; Zhang W; Zhang J; Zhao R; Yu Z; Dong K; Wang H
Comb Chem High Throughput Screen; 2023; 26(8):1488-1502. PubMed ID: 36200154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
